In our study, we did not find significant differences in EBNA-1 or VCA IgG prevalences or titers in relation to HLA-DRB1*15:01 or the vitamin D levels nor in MS group nor in control group. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.